From the Edmonton Sun:
An Edmonton doctor says the health of Canadian cancer patients is being threatened by a government-appointed agency that makes decisions on provincial drug funding.
The Common Drug Review (CDR) is using a decision-making process that is flawed, said Dr. Scott North, a medical oncologist at the Cross Cancer Institute.
North explained that the CDR recently reviewed two new drugs for the treatment of kidney cancer.
One of the drugs, Nexavar, was found to be especially effective halfway through one recent clinical trial, North said. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment